These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3388482)

  • 21. Regulation of receptors and digestive activity toward synthesized formyl-chemotactic peptide in human polymorphonuclear leukocytes.
    Nunoi H; Endo F; Chikazawa S; Matsuda I
    Blood; 1985 Jul; 66(1):106-14. PubMed ID: 2988664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
    J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis.
    Perez HD; Kelly E; Elfman F; Armitage G; Winkler J
    J Clin Invest; 1991 Mar; 87(3):971-6. PubMed ID: 1999504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogen ion maintenance improves the chemotaxis of stored granulocytes.
    Lane TA; Lamkin GE
    Transfusion; 1984; 24(3):231-7. PubMed ID: 6729938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression.
    Zimmerli W; Seligmann B; Gallin JI
    J Clin Invest; 1986 Mar; 77(3):925-33. PubMed ID: 3005369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of ligand binding regions of the human formyl peptide receptor.
    Radel SJ; Genco RJ; De Nardin E
    Biochem Int; 1991 Nov; 25(4):745-53. PubMed ID: 1815508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
    Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
    Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Volume dependent polymorphonuclear leukocytes fractions isolated by counterflow centrifugal elutriation: PMN volume does not correlate with PMN age.
    Berkow RL; Dodson RW
    J Leukoc Biol; 1987 Jun; 41(6):518-26. PubMed ID: 3036985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemical characterization of the formyl peptide receptor moieties on human neutrophils.
    De Nardin E; Genco RJ
    Hybridoma; 1991 Feb; 10(1):49-63. PubMed ID: 1709613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterologous receptor population for a chemotactic factor F-Met-Leu-Phe on the human neutrophil. Effect of pH and temperature.
    Mehta J; Spilberg I
    Inflammation; 1983 Sep; 7(3):301-9. PubMed ID: 6681323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down-regulation.
    Skubitz KM; Hammerschmidt DE
    Blood; 1986 Oct; 68(4):830-6. PubMed ID: 3756350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes.
    Fletcher MP
    J Immunol; 1987 Dec; 139(12):4167-73. PubMed ID: 3693900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diclofenac binding to human polymorphonuclear neutrophils: effect on respiratory burst and N-formylated peptide binding.
    Perianin A; Gougerot-Pocidalo MA; Giroud JP; Hakim J
    Biochem Pharmacol; 1987 Aug; 36(16):2609-15. PubMed ID: 3300657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formyl peptide-induced chemotaxis of human polymorphonuclear leukocytes does not require either marked changes in cytosolic calcium or specific granule discharge. Role of formyl peptide receptor reexpression (or recycling).
    Perez HD; Elfman F; Marder S; Lobo E; Ives HE
    J Clin Invest; 1989 Jun; 83(6):1963-70. PubMed ID: 2723068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
    Anderson DC; Hughes BJ; Smith CW
    J Clin Invest; 1981 Oct; 68(4):863-74. PubMed ID: 7287906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shedding of tumor necrosis factor receptors by activated human neutrophils.
    Porteu F; Nathan C
    J Exp Med; 1990 Aug; 172(2):599-607. PubMed ID: 2165128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.